GS-9973: Interim Phase II data

Interim data from 78 evaluable patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or non-Hodgkin's lymphoma (NHL) in the single-arm, open-label, U.S. Phase II Study 102 showed tha...